Ligand validation:2FZW

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 2FZW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2FZW_NAD_B_2377	83%	7%	0.106	0.965	2.88	1.88	9	13	2	0	100%	1
2FZW_NAD_A_1377	79%	9%	0.102	0.947	2.7	1.73	9	11	1	0	100%	1
1MP0_NAD_B_778	96%	14%	0.068	0.978	1.98	1.86	6	8	2	0	100%	1
1MA0_NAD_B_6377	94%	14%	0.079	0.977	2	1.89	8	7	3	0	100%	1
3QJ5_NAD_B_374	92%	28%	0.087	0.979	1.65	1.27	3	3	2	0	100%	1
1TEH_NAD_A_377	90%	15%	0.092	0.973	2.17	1.66	9	9	1	0	100%	1
1MC5_NAD_B_501	73%	13%	0.138	0.964	2.14	1.88	9	12	2	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	10%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.